Previous data indicated that MIF has a hepatoprotective effect in steatosis and fibrosis by promoting the CD74/AMPK pathway in hepatocytes and Mif–/– mice on a non-Western-type HFD showed enhanced lipid accumulation in the liver, which was associated with upregulated Srebp-1 and Fasn levels24,93. Here, FASN is linked to steatosis.